Skip to content

News & Media

4th June 2020
FDA Approves Elixirgen Therapeutics IND Application for Therapy for Telomere Biology Disorders with Bone Marrow Failure
4th June 2020
Elixirgen Therapeutics Concludes pre-IND Meeting with FDA for its COVID-19 Vaccine Candidate EXG-5003
9th July 2018
Elixirgen Therapeutics, Inc. raises $4 million in Series A funds
7th May 2018
Elixirgen Therapeutics, LLC now Elixirgen Therapeutics, Inc.
30th May 2017
Elixirgen Therapeutics successfully concludes pre-IND meeting with FDA
31st August 2015
Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures
24th March 2010
Zscan4 regulates telomere elongation and genomic stability in ES cells
15th July 2007
Zscan4: A novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells
Top